Revotek initiated a unique 3D Bioprinting system which takes “Biosynsphere” as core technology, utilizes RevoCloud Mega Data computing platform as a “mapping” tool, and takes Revotek 3D Bioprinters as the fabricating tool. This system makes fabrication of personalized functional human organs possible.

Our unique suite of technologies includes:

Biosynsphere™: Specialized bio-ink preparations that enable scaffold free bio-printing
Bioprinters: T and B series printers with specialized nozzles and platforms to print synthetic and bio-materials
RevoCloud™: 2D to 3D image conversion technology

In December 2016, we became the first known company to successfully implant a 3D printed organ into living hosts during a series of animal trials using our proprietary and patented technologies. Every one of our test subjects survived and fully accepted the bio-grafts.

Revotek has been granted 14 patents to date with an additional 56 under review with new submissions added regularly as we continue developing our technology and methods.

We are currently in discussions with the US FDA seeking approval to begin clinical trials for our 3D bio-grafts.

RevoCloud - Proprietary 2D to 3D Imaging Software

Software Details